PA 10-72—SB 281

Human Services Committee

AN ACT CONCERNING PUBLIC PARTICIPATION IN MEETINGS OF THE PHARMACEUTICAL AND THERAPEUTICS COMMITTEE

SUMMARY: This act requires the Pharmaceutical and Therapeutics (P & T) Committee, which establishes and monitors the Department of Social Services' (DSS) preferred drug list, to ensure that its meetings include an opportunity for public comment.

By law, the committee (1) must provide notice of all of its meetings and (2) may seek public participation in its deliberations on an ad hoc basis. In practice, the committee's guidelines allow for public comment during the first half-hour of the committee's meetings.

EFFECTIVE DATE: July 1, 2010

BACKGROUND

P & T Committee Guidelines for Public Comment

The P & T Committee has published guidelines for public comment on the Department of Social Services' Medical Assistance Program website. They (1) allow members of the public to submit clinical and other relevant information to the committee and request an opportunity to speak at a meeting and (2) require speakers to submit a written document, no longer than 10 pages, at least two weeks before the meeting, outlining the subject to be covered.

At least one week before the meeting, the committee must notify the person who will be permitted to speak and give him or her an approximate time to appear before the committee.

At the chairperson's discretion, (1) speakers have a limit of five minutes and (2) committee members may question them.

OLR Tracking: RC: JK: VR: ts